Studies on The Ingredients in NeuropathyRx® |
|
Beneficial results on NeuropathyRx® as published in the July/August issue of Practical Pain Management. |
 |
Diabetic Neuropathy Study
Abstract - Printed in the Jul/Aug 2007 edition of The Journal of Practical Pain Management
by Mark Gostine, MD; Larry Pawl, MD; Michael David, DPM; and William Decker, DPM
Diabetic neuropathies are a consequence of long term hyperglycemia and occur whether the diabetes is insulin dependent or not. In patients with juvenile diabetes, these problems arise in the third through fifth decade and, in type two diabetes, usually after the fifth decade of life. Focal mononeuropathies can cause third and sixth cranial nerve palsies, painful intercostal neuropathy, and isolated muscle weakness involving the hip girdle. These mononeuropathies are likely vascular in origin and usually resolve over a period of months. While the distal symmetrical neuropathies may have an element of ischemia, they most likely represent a confluence of metabolic disturbances.
There are multiple characteristics used to classify diabetic neuropathy including whether they are symmetric or asymmetric, sensory or autonomic, mononeuropathy or polyneuropathy, and entrapment neuropathy or not. Many patients have mixed varieties of neuropathy involving the sensory nerves of the distal limbs and the autonomic nervous system. Autonomic neuropathies can result in disturbances of gastrointestinal, sexual, and vasomotor functions. Many of the sensory neuropathies involve pain which is frequently described as burning and numbness. These symptoms interfere with sleep, daily activities, and quality of life.
While the treatment of diabetic neuropathy has improved with the use of antiepileptic drugs and antidepressants, it still remains frustrating. Most of the commonly used medications have anticholinergic side effects or cause sedation. At best, they are only partially effective because they do not treat the underlying cause of the neuropathy but only the symptoms. The goal of this study was to determine if we could improve patients’ reports of pain and numbness with the utilization of nutritional supplements that may partially address the causes of diabetic complications. |
| |
|
|
|
| |
|
|
|
| Safety Facts | Quality | SuccessStories | FAQ's | Contact Us | Home |
|
Privacy & Security Policies |
|
NeuropathyRx © 2010 | **Orders outside of the US are not eligible for free shipping. |
* NeuropathyRx® for treatment of peripheral neuropathy, diabetic neuropathy, neurofibromatosis, fibromyalgia, and multiple sclerosis. We specialize in neuropathy, neurofibromatosis, nerve, and neurological treatment through the use of natural vitamin supplements specifically formulated for the treatment of neuropathy and neurofibromatosis. Information contained on this site is not intended to diagnose, prescribe for, treat, or claim to prevent, mitigate or cure any disease. While literature suggests that the supplements made available on this site may be very helpful in the treatment of neuropathy, neurofibromatosis, fibromyalgia, multiple sclerosis and other neurological conditions, they have not been approved by the Food and Drug Administration and individual results may vary. Consumers are cautioned to read all labels and follow all directions. Please consult with your health care provider before using these products to treat your neuropathy, neurofibromatosis, fibromyalgia, or multiple sclerosis. The information on this website should not in any way be used as a substitute for the advice of a physician or other licensed health care practitioner. We shall not be held liable or responsible to any person or entity for any loss or damage caused, or alleged to be have been caused, directly or indirectly by the information or ideas contained, suggested, or referenced on this web site. Please take a moment to read our studies on neuropathy and neurofibromatosis and learn how we discovered NeuropathyRx® for treatment of neuropathy pain, neuropathy burning, neuropathy numbness, and all forms of peripheral neuropathy including diabetic neuropathy and neuropathy induced by chemotherapy in addition to neurofibromatosis. |
 |
|
|
